美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Trust Health Care AlphaDEX Fund

130.77

-0.7900-0.60%

盤後：130.770.00000.00%19:30 EDT

成交量：5.30萬

成交額：694.22萬

市值：11.38億

市盈率：- -

高：131.65

開：131.30

低：130.60

收：131.56

52周最高：135.82

52周最低：104.53

股本：870.00萬

流通股本：870.00萬

量比：0.62

換手率：0.61%

股息：1.03

股息率：0.78%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

中國減肥藥研發公司德睿智藥稱AI助力研發時間縮短一半

美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.44億美元，用於改善心理健康、藥物濫用、急診及孕產婦護理，並擴大阿

惠譽評級：美國醫療保健網絡風險日益增加。

減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？

法院批准哈門那子公司助理上訴許可

Humana同意在美國的藥品訴訟中不提及Teva與以色列的關聯

美國總統特朗普：醫療補助將不再為未成年人提供性別轉換手術和激素治療的資金。

板塊普漲之際十隻量化評分強勁的大盤醫療保健股

哈門那旗下健康視野計劃攜手健康流科技，共築印第安納州家庭護理人才高地

30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨

小摩上調哈門那目標價至393美元

Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升

GLP-1為王、專利懸崖逼近、新賽道搶跑跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

特瓦公司試圖向陪審團隱瞞與以色列的關聯，並援引加沙戰爭作為理由

美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥

安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發

环球市场播报

阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大

重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案

重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/FXH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","market":"US","secType":"STK","nameCN":"First Trust Health Care AlphaDEX Fund","latestPrice":130.77,"timestamp":1789761600000,"preClose":131.56,"halted":0,"volume":53026,"hourTrading":{"tag":"盘后","latestPrice":130.77,"preClose":130.77,"latestTime":"19:30 EDT","volume":17,"amount":2222.65,"timestamp":1789774206358,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006004864700516814,"floatShares":8700002,"shares":8700002,"eps":0,"marketStatus":"休市中","change":-0.79,"latestTime":"09-18 16:00:00 EDT","open":131.3,"high":131.65,"low":130.595,"amount":6942185.6606600005,"amplitude":0.008019,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":131.56,"sharesOutstanding":7900002,"nav":131.82,"aum":1146834263.64,"dividendRate":0.007847,"bidAskSpread":0.000902,"preHourTrading":{"tag":"盘前","latestPrice":132.1,"preClose":131.56,"latestTime":"06:50 EDT","volume":10,"amount":1319.9199999999998,"timestamp":1789728600185,"change":0.54,"changeRate":0.004105,"amplitude":0.004105},"postHourTrading":{"tag":"盘后","latestPrice":130.77,"preClose":130.77,"latestTime":"19:30 EDT","volume":17,"amount":2222.65,"timestamp":1789774206358,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6151522399032501,"impliedVol":0.1506,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","floatShares":8700002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6151522399032501,"shares":8700002,"dividePrice":1.0262,"high":131.65,"amplitude":0.008019,"preClose":131.56,"low":130.595,"week52Low":104.525,"pbRate":"--","week52High":135.8199,"institutionHeld":0,"latestPrice":130.77,"eps":0,"divideRate":0.007847,"volume":53026,"delay":0,"ttmEps":0,"open":131.3,"prevYearClose":113.8213,"prevWeekClose":129.66,"prevMonthClose":132.89,"prevQuarterClose":122.4,"fiveDayClose":129.66,"twentyDayClose":133.87,"sixtyDayClose":118.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FXH","amount":0.1183,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FXH","amount":0.1858,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FXH","amount":0.1399,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FXH","amount":0.5821,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FXH","amount":0.0616,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXH\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-23","recordDate":"2022-09-26","paymentDate":"2022-09-30","value":0.1007,"currency":"USD"},{"executeDate":"2022-12-23","recordDate":"2022-12-27","paymentDate":"2022-12-30","value":0.1214,"currency":"USD"},{"executeDate":"2023-03-24","recordDate":"2023-03-27","paymentDate":"2023-03-31","value":0.0438,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-06-30","value":0.0377,"currency":"USD"},{"executeDate":"2023-09-22","recordDate":"2023-09-25","paymentDate":"2023-09-29","value":0.0332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662376416","title":"中國減肥藥研發公司德睿智藥稱AI助力研發時間縮短一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2662376416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662376416?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 12:03","pubTimestamp":1787717002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FHLC","PJP","ARTY","QTOC","RSPH","TRUH","NVOC","CHAT","THNR","NBDS","NVOH","CURE","AIPO","FXH","AGIX","NVOX","PINK","IYH","XLVI","MEDI","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662420944","title":"美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.44億美元，用於改善心理健康、藥物濫用、急診及孕產婦護理，並擴大阿","url":"https://stock-news.laohu8.com/highlight/detail?id=2662420944","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662420944?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 05:51","pubTimestamp":1787608316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1983260115.SGD","LU0417517546.SGD","RSPH","FXH","BK4533","BK4585","SG9999014005.SGD","LU0070302665.USD","HUM","UNHG","BK4588","SG9999014013.SGD","LU0266013472.USD","LU0348723411.USD","LU0211331839.USD","LU0238689110.USD","UNHW","LU0170899867.USD","UNHU","LU0256863811.USD","IEHS","IHF","LU0208291251.USD","BK4154","LU1093756325.SGD","LU0320765489.SGD","LU0390134368.USD","UN","LU1093756168.USD","SG9999014021.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660649212","title":"惠譽評級：美國醫療保健網絡風險日益增加。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660649212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660649212?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 04:43","pubTimestamp":1787085794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PINK","JHMH","FXH","BK4588","CURE","PTH","BK4585","HYLG","MOAT","RSPH","IYH","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FXH","PINK","THNR","RSPH","XLVI","CURE","IYH","TRUH","NBDS","MEDI","NVOC","PJP","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108678606","title":"法院批准哈門那子公司助理上訴許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1108678606","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108678606?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:20","pubTimestamp":1786713624,"startTime":"0","endTime":"0","summary":"8月14日（路透社）——哈门那公司（Humana AB）宣布，上诉法院已正式批准其子公司哈门那助理公司（Humana Assistans AB）的上诉请求。该上诉涉及地方法院此前驳回其针对国家损害赔偿诉讼的裁决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","FXH","BK4585","BK4533","SG9999014005.SGD","SG9999014013.SGD","LU0070302665.USD","LU0266013472.USD","LU0320765489.SGD","LU0348723411.USD","LU1983260115.SGD","LU1093756168.USD","LU0417517546.SGD","LU0170899867.USD","BK4154","BK4588","LU0256863811.USD","SG9999014021.USD","HUM","BK4566","LU0208291251.USD","IHF","LU0238689110.USD","LU0211331839.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112168","title":"Humana同意在美國的藥品訴訟中不提及Teva與以色列的關聯","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112168","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 22:18","pubTimestamp":1786630699,"startTime":"0","endTime":"0","summary":"Humana和特瓦尚未立即回应置评请求。Humana在周三提交的文件中表示，其律师在庭审期间“在辩论或质询中不会提及特瓦是一家以色列公司这一事实”。特瓦否认了Humana的指控，即该公司与其他制药商串通，人为抬高某些药物的价格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4S44A17Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXH","LU0070302665.USD","LU0170899867.USD","SG9999014021.USD","LU0417517546.SGD","LU0266013472.USD","LU0211331839.USD","SG9999014005.SGD","LU1093756168.USD","LU1093756325.SGD","IHF","BK4566","BK4533","BK4588","HUM","LU1983260115.SGD","LU0320765489.SGD","BK4154","SG9999014013.SGD","LU0238689110.USD","LU0390134368.USD","LU0208291251.USD","BK4585","LU0256863811.USD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658469849","title":"美國總統特朗普：醫療補助將不再為未成年人提供性別轉換手術和激素治療的資金。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658469849","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658469849?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 05:23","pubTimestamp":1786483407,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1983260115.SGD","LU0238689110.USD","LU0256863811.USD","LU0417517546.SGD","FXH","LU1093756168.USD","LU0070302665.USD","SG9999014005.SGD","SG9999014021.USD","HUM","IHF","LU1093756325.SGD","LU0266013472.USD","BK4588","BK4533","LU0390134368.USD","LU0208291251.USD","LU0320765489.SGD","BK4585","BK4154","BK4566","RSPH","LU0170899867.USD","SG9999014013.SGD","LU0211331839.USD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911935","title":"板塊普漲之際 十隻量化評分強勁的大盤醫療保健股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911935","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911935?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:27","pubTimestamp":1786462073,"startTime":"0","endTime":"0","summary":"经历 2022-2023年板块低迷后，医疗保健板块在2026年重新积聚上涨动能。Centene Corporation以4.97分接近满分的量化评分位居榜单首位；Corcept Therapeutics、Bright Spring Health Services紧随其后，评分分别为4.93、4.91；Halozyme Therapeutics、Humana跻身前五，均获强烈“买入”评级。即便板块整体处在历史高位，个股之间量化评分分化依旧显著。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303689","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","LU1066051811.HKD","LU1267930730.SGD","IE00B19Z3B42.SGD","IE0004445015.USD","LU0672654240.SGD","LU2028103732.USD","LU0353189763.USD","LU2089283258.USD","LU2089984988.USD","BK4533","LU2089284900.SGD","IXJ","IE00B19Z9P08.USD","LU2244417387.USD","LU0320765059.SGD","LU0149725797.USD","LU2112291526.USD","LU0208291251.USD","BK4504","DVA","BK4532","BK4534","NBIX","LU1261432733.SGD","XLV","LU2468319806.SGD","LU0390134368.USD","BK4528","IE00B775H168.HKD","LU0128525689.USD","LU0320765992.SGD","CNC","LU0094547139.USD","LU0342679015.USD","LU0553294199.USD","LU1674673428.USD","IE00B19Z8W00.USD","LU0154245756.USD","SG9999013999.USD","LU0738911758.USD","LU0077335932.USD","LU2360032135.SGD","LU1548497426.USD","HALO","LU0708994859.HKD","LU0109391861.USD","IE00BJJMRY28.SGD","JDOC","IE0002141913.USD","SG9999014906.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU0130518102.USD","LU0143551892.USD","SG9999014021.USD","LU0496365809.HKD","LU0320765489.SGD","LU1064131342.USD","LU2023251221.USD","LU2125154778.USD","LU0114720955.EUR","LU2264538146.SGD","LU0053671581.USD","FXH","LU0345770993.USD","IE0034235188.USD","LU1551013342.USD","BK4196","BK4007","SOLV","LU0187121727.USD","IE00B7KXQ091.USD","LU0170899867.USD","LU0130517989.USD","LU2065171311.SGD","LU0203347892.USD","IE0002270589.USD","LU1037948541.HKD","IE00B19Z8X17.USD","TMED","LU0310800965.SGD","LU1201861165.SGD","LU0965509283.SGD","LU1989764664.SGD","LU2552382058.USD","LU1069347547.HKD","LU1699723380.USD","LU0345770308.USD","LU2347655156.SGD","LU1718418525.SGD","LU0477156797.USD","LU0107464264.USD","LU1061106388.HKD","VHT","SG9999018865.SGD","LU2111349929.HKD","LU1074936037.SGD","LU1093756325.SGD","LU2065171402.SGD","LU1814569148.SGD","SG9999002232.USD","LU0122379950.USD","LU0648001328.SGD","LU0029864427.USD","SG9999001176.USD","LU0545039389.USD","LU0965508806.USD","LU1732799900.SGD","IE00B3T34201.USD","LU0266013472.USD","UNH","IE00BKVL7J92.USD","PTH","IE000M9KFDE8.USD","LU0882574055.USD","LU0432979614.USD","LU1066051498.USD","LU1559883803.SGD","IE00BFSS7M15.SGD","LU1791710400.SGD","LU0070302665.USD","BK4559","LU1066051225.USD","LU2954938101.SGD","LU2357627491.SGD","SG9999014898.SGD","LU0965509101.SGD","BK4566","LU0154245673.USD","CNCG","LU0158827781.USD","LU0861579265.USD","LU1496350502.SGD","SGXZ99366536.SGD","BK4198","BK4588","LU0980610538.SGD","SG9999018857.SGD","UNHW","LU0162691827.USD","LU0072461881.USD","LU0949170772.SGD","IE00B1XK9C88.USD","LU0795875086.SGD","IE00B1BXHZ80.USD","LU1778281490.HKD","LU1983260115.SGD","LU2361044949.HKD","LU1037948897.HKD","PSCH","LU1119994496.HKD","IE00BN29S564.USD","LU1066053197.SGD","LU0211326755.USD","IE0004445239.USD","LU1988902786.USD","IE00BJT1NW94.SGD","BK4613","LU0203345920.USD","LU1093756168.USD","IE0009355771.USD","LU0211327993.USD","LU2271345857.HKD","IHF","LU2491050154.USD","TRUH","LU0820561909.HKD","LU0130102774.USD","EKG","IE00B4R5TH58.HKD","LU2211815571.USD","LU0912757837.SGD","IE0005OL40V9.USD","LU1267930227.SGD","LU0661504455.SGD","LU0477156953.USD","LU0109394709.USD","BK4585","LU2324357040.USD","SG9999017495.SGD","BK4167","LU0683600562.USD","IE00B19Z9Z06.USD","LU2242649171.HKD","LU0648000940.SGD","LU1914381329.SGD","LU0310799852.SGD","LGHT","LU1791710582.SGD","IE00B19Z9505.USD","LU1201861249.SGD","FHLC","FBT","LU0211326839.USD","IE00BKPKM429.USD","LU0316494557.USD","SGXZ51526630.SGD","LU1670627923.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0353189680.USD","LU0417517546.SGD","LU1989764748.USD","LU0310800379.SGD","LU0528227936.USD","LU2362541273.HKD","LU1084165304.USD","BK4154","SGXZ81514606.USD","LU1003077747.HKD","IE00BZ1G4Q59.USD","LU0976567544.SGD","SG9999014013.SGD","LU0130103400.USD","LU1934455863.HKD","LU1720051108.HKD","SG9999014880.SGD","LU1854103824.USD","LU0859254822.USD","LU1057294990.SGD","LU2999663052.SGD","LU2133065610.SGD","LU1153585028.USD","LU2087625088.SGD","LU0011850046.USD","LU0820561818.USD","LU1323610961.USD","LU0795875169.SGD","LU0557290698.USD","LU2236285917.USD","LU0198837287.USD","IYH","LU0348723411.USD","LU0052756011.USD","LU1934455277.USD","SG9999002224.SGD","LU0097036916.USD","LU0289739699.SGD","LU0256863811.USD","IE00BWXC8680.SGD","LU0079474960.USD","LU0456855351.SGD","IE00B894F039.SGD","UNHG","CORT","LU1267930573.SGD","MHIP","HRTS","LU0211331839.USD","LU1983299246.USD","LU1989771016.USD","FFOX","LU1720051017.SGD","LU1035773651.USD","BK4581","SGXZ57979304.SGD","LU0354030511.USD","LU2462591277.SGD","LU0787776722.HKD","LU2361045086.USD","LU1934455194.USD","IE00BZ9MQY76.HKD","LU2491050071.SGD","SG9999001176.SGD","BK4139","LU1670628061.USD","IE00BJJMRZ35.SGD","SG9999014914.USD","LU0158827948.USD","LU0823416689.USD","LU0566484027.USD","LU2461242641.AUD","LU1291159041.SGD","LU1854104046.USD","IE00BFSS8Q28.SGD","IE00BJJMRX11.SGD","LU2065170008.USD","GDOC","LU0251132253.USD","SGXZ31699556.SGD","LU0689472784.USD","IE00B7SZLL34.SGD","LU0058720904.USD","LU2552382215.SGD","IE00B4JS1V06.HKD","LU2279689827.SGD","LU0128525929.USD","LU0943347566.SGD","LU0889565916.HKD","LU2552382132.HKD","LU1506573853.SGD","LU2362540622.SGD","IE00BFXG1179.USD","LU0211328371.USD","LU0053666078.USD","LU0965509010.AUD","HUM","LU2065169927.USD","LU2362541513.USD","LU1267930490.SGD","LU0238689110.USD","LU0820562030.AUD","LU0708995401.HKD","LU1023059063.AUD","LU2357305700.SGD","VEEV","LU0048584097.USD","LU2125154935.USD","LU2491049909.HKD","IE00BSNM7G36.USD","LU1732800096.USD","LU0234572021.USD","LU1674673691.USD","BTSG","RXL","SG9999014005.SGD","LU2361044865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178334778","title":"哈門那旗下健康視野計劃攜手健康流科技，共築印第安納州家庭護理人才高地","url":"https://stock-news.laohu8.com/highlight/detail?id=1178334778","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178334778?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:02","pubTimestamp":1786449722,"startTime":"0","endTime":"0","summary":"哈门那（Humana）在印第安纳州推出的“健康视野”（Healthy Horizons）计划，正与健康流科技（HealthStream）展开深度合作。此次携手，旨在扩充并夯实家庭护理领域的人才队伍。这项举措，恰似一场及时雨，为当地护理行业注入新的活力。通过整合双方资源，它们致力于吸引更多专业人才投身于家庭护理工作，并进一步提升现有从业者的技能水平。此举不仅关乎个人职业发展，更将对整个社区的健康服务体系产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0348723411.USD","HSTM","LU0070302665.USD","HUM","BK4154","LU0208291251.USD","SG9999014021.USD","FXH","BK4533","LU0320765489.SGD","LU0266013472.USD","LU1093756168.USD","SG9999014005.SGD","LU0238689110.USD","IHF","LU0390134368.USD","LU0256863811.USD","LU1093756325.SGD","BK4588","BK4167","LU0170899867.USD","BK4566","LU1983260115.SGD","LU0211331839.USD","SG9999014013.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["PJP","CURE","MEDI","PINK","THNR","GLP","FXH","FHLC","RSPH","TRUH","NVOC","IYH","BK4144","BK4590","JDOC","NBDS","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658696761","title":"小摩上調哈門那目標價至393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658696761","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658696761?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 14:46","pubTimestamp":1786430776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UDN","SG9999014021.USD","FXH","LU0390134368.USD","LU1983260115.SGD","LU0211331839.USD","LU0266013472.USD","LU0348723411.USD","LU0256863811.USD","SG9999014005.SGD","BK4154","LU0070302665.USD","LU0320765489.SGD","LU1093756325.SGD","SG9999014013.SGD","LU0208291251.USD","UUP","LU0170899867.USD","HUM","LU0238689110.USD","BK4588","IHF","LU0417517546.SGD","BK4566","LU1093756168.USD","BK4585","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969925?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FHLC","THNR","MEDI","XLVI","CURE","TRUH","PJP","NBDS","PINK","RSPH","NVOC","FXH","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658535936","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑 跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535936","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535936?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363243,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836820982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836820982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","MEDI","BBP","RSPH","FXH","BBH","BK4590","BK4144","BME","PBPH","IHE","GSKH","TRUH","PPH","JDOC","TMED","PJP","IYH","FHLC","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641919","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641919","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641919?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:49","pubTimestamp":1786110543,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835488463.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835488463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BBP","RSPH","FXH","APXH","BME","GSKH","BBH","IYH","FHLC","TRUH","MEDI","PBPH","BK4590","PJP","IHE","TMED","JDOC","GLP","PPH","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655274","title":"特瓦公司試圖向陪審團隱瞞與以色列的關聯，並援引加沙戰爭作為理由","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655274","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655274?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 00:19","pubTimestamp":1786033193,"startTime":"0","endTime":"0","summary":"特瓦公司试图向陪审团隐瞒与以色列的关联，并援引加沙战争作为理由特瓦指出，自加沙战争以来，对以色列的敌意日益加剧这家制药公司表示，公司起源与本案无关关于定价指控的庭审定于下月举行Mike Scarcella路透华盛顿8月6日-特瓦制药公司已请求美国法官禁止保险公司胡玛纳在一场重大的药品价格垄断审判中向陪审团透露其是一家以色列公司，理由是公众对加沙战争  的强烈看法可能会影响审判程序，并影响该公司获得公正审理的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4S44321U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHF","BK4559","LU0256863811.USD","LU0266013472.USD","LU2324357040.USD","SG9999014013.SGD","LU0417517546.SGD","LU1093756325.SGD","LU0320765489.SGD","LU0348723411.USD","BK4007","BK4588","BK4584","LU1983260115.SGD","SG9999014021.USD","BK4596","LU0070302665.USD","LU0211331839.USD","TEVA","FXH","BK4585","LU1983299246.USD","SG9999014005.SGD","HUM","LU0390134368.USD","LU0208291251.USD","BK4566","BK4557","BK4533","LU1093756168.USD","LU0238689110.USD","BK4154","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657896386?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BAC","KBWB","ELIL","LLYX","THNR","LLYZ","GLP","LU1280957306.USD","PINK","RSPH","IE00BZ1G4Q59.USD","IYG","MEDI","PJP","XLVI","NVOC","UYG","LU0130103400.USD","JDOC","LU0648001328.SGD","LU1496350171.SGD","BK4534","IE0001KFT4U8.USD","IYH","IE00B19Z3B42.SGD","FTXO","VFH","TFNS","CURE","BK4590","IYF","ELIS","LU0980610538.SGD","FHLC","LU1506573853.SGD","LLII","LU0106831901.USD","LU0170899867.USD","FNCL","IE00BBT3K403.USD","LU0211331839.USD","TRUH","NBDS","BK4588","OZEM","LU0314106906.USD","FXH","LU0053666078.USD","PGF","XLF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657674945?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"us","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1571399168.USD","BK4566","TBXU","LU0889565916.HKD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","IBBQ","IE00BJT1NW94.SGD","LU1983299246.USD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","BIB","PINK","BK4599","FXH","BK4588","IE00BJJMRZ35.SGD","BK4581","FHLC","LU0109394709.USD","LU0289739699.SGD","LU0320765992.SGD","BK4139","BBH","CURE","IYH","BK4533","PJP","LU1023059063.AUD","IE00B2B36J28.USD","LU0868494617.USD","LU1061106388.HKD","AMGN","LU2468319806.SGD","BK4534","THNR","IE00B4R5TH58.HKD","RSPH","NVOC","TRUH","PBE","IE00BFTCPJ56.SGD","XLVI","IBB","MEDI","IE0009355771.USD","NBDS","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BBH","LU1868836591.USD","LU0321505439.SGD","IYH","BME","RSPH","LU2596442595.SGD","FXH","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU2242646821.SGD","JDOC","LU2237443895.HKD","MEDI","PBPH","AZ","LU1032466523.USD","IHE","LU0267386448.USD","LU0321505868.SGD","LU1670711123.USD","LU2462157665.USD","AZNH","LU0882574055.USD","LU1868836914.USD","AZN","LU1868837300.USD","LU0985481810.HKD","PPH","LU0432979614.USD","LU1670710588.SGD","LU0128525929.USD","LU2237443382.USD","BK4588","FHLC","LU1585245621.USD","FTXH","BBP","IE00B2B36J28.USD","TMED","PJP","APXH","BK4559","LU0868494617.USD","LU2089984988.USD","LU0225284248.USD","GSKH","TRUH","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346866","title":"重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346866","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346866?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，阿斯利康已就收购百时美施贵宝展开探讨，这桩超级交易若达成，将缔造全球规模最大的制药企业之一。阿斯利康市值超过百时美施贵宝百时美施贵宝正为其部分最核心产品面临专利保护到期做准备，包括抗凝药艾乐妥与抗癌药欧狄沃。两款产品合计约占百时美施贵宝销售额的一半。上周，百时美施贵宝公布季度销售额 130 亿美元，创历史最高。阿斯利康目前是伦敦证券交易所市值第二大的公司。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZN","LU0029864427.USD","LU1718418525.SGD","LU0061475181.USD","IE00BFTCPJ56.SGD","LU2237443978.SGD","RXL","AZNH","LU1323610961.USD","XBIX","LU2360032135.SGD","IHE","LU1093756325.SGD","PILL","IE0009355771.USD","SYNB","BK4534","LU2237443382.USD","JHMH","IE00B3T34201.USD","LU1032466523.USD","LU2237443622.USD","LU1992135472.HKD","LU2456880835.USD","LU2473716301.USD","PPH","FTXH","RXD","LU0432979614.USD","BK4559","LU0096364046.USD","XPH","LU1291159041.SGD","IEHS","FXH","LU1585245621.USD","BMY","LU2237443465.HKD","IE00B5TLWC47.USD","CURE","LU2237443549.SGD","LU2272731600.USD","FHLC","MEDI","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","LU0456855351.SGD","LU2125154778.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468693","title":"重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468693?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:25","pubTimestamp":1785713101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009355771.USD","XBIX","IHE","LU1267930573.SGD","LU0237698245.USD","LU0306807586.USD","IE00BFTCPJ56.SGD","IEHS","IE0002141913.USD","BK4581","LU0225771236.USD","LU1032466523.USD","SYNB","XPH","IE00BSNM7G36.USD","FHLC","LU2125154935.USD","BMY","LU1670711123.USD","LU2272731782.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","IE00B3T34201.USD","JHMH","LU1989771016.USD","LU2596442595.SGD","MEDI","RXD","BK4534","PPH","LU2456880835.USD","LU0985481810.HKD","IE00B5TLWC47.USD","CURE","AZN","IE00BFXG1179.USD","AZNH","LU1074936037.SGD","LU2089984988.USD","LU0058720904.USD","LU1868837136.USD","PILL","LU1868836914.USD","LU1670710661.SGD","LU0456855351.SGD","FTXH","RXL","FXH","LU0029864427.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":74,"code":"91000000","status":"200"}]}}